What is ‘Premium Content’ on Pharmaceutical Technology?
Pharmaceutical Technology has introduced new ‘Premium Content’ for its readers – here’s an explanation of what’s changing and what isn’t.…
All articles by Catherine Longworth
Catherine Longworth
@MedtechCate
Catherine Longworth is Healthcare Editor-in-Chief at GlobalData, where she leads coverage of updates across pharma, biotech, medical technology, and health tech. With a background in biomedical science and journalism, she has reported on healthcare developments across multiple regions since 2016, bringing a global perspective to her work. Catherine has extensive experience leading B2B publications and is recognised for delivering insightful, accurate, and forward-looking reporting. She frequently moderates international industry panels and conferences, connecting audiences with thought leaders from around the world.
-
-
Between two giants: Europe’s new oncology chapter takes shape in Paris
The opening of THE HIVE at Campus Grand Parc was marked not simply by the inauguration of a new laboratory…
-
Validation to velocity: Japan’s pharma model comes under execution pressure
Japan’s pharmaceutical industry - the world’s third largest by market value after the United States and China - has long…
-
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched…
-
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has…
-
Estonia’s digital health DNA: Trust, data, and biotech in focus
With just 1.3 million residents, Estonia’s digital footprint far exceeds its size. When Barack Obama visited Tallinn in 2014, he…
-
Navigating regulatory change in APAC: Insights from the upcoming BioSecure Act Webinar
The regulatory landscape across the Asia-Pacific (APAC) region is evolving rapidly, and pharmaceutical companies must adapt to maintain compliance, mitigate…
-
Europe’s cannabis pharmaceuticals market matures amid cautious investment
Europe’s cannabis pharmaceutical market is far from a gold rush, yet it is emerging as one of the more strategic…
-
Synthetic rescue: Insmed explores a new frontier in genetic therapeutics
Nestled on the southern fringe of Cambridge within the Babraham Research Campus, US-based biopharma Insmed is laying the groundwork for…
-
London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine
The inaugural London Biotechnology Show was a major hit with over 3,000 attendees present at the event, including representatives from…